| Document |
Document Title |
|
WO/2018/038400A1 |
The present invention relates to a novel compound and an organic electroluminescence device including same. The compound according to the present invention may be used in an organic material layer, preferably, a light emitting layer, of ...
|
|
WO/2018/032356A1 |
A novel process for the preparation of lactone derivatives, and intermediates thereof is described. The lactone derivatives are important precursors for the synthesis of anti-hepatitis C virus agents, including sofosbuvir.
|
|
WO/2018/033635A1 |
The invention relates to a process for the preparation of 2,2,5,5- tetramethyltetrahydrofuran (TMTHF) comprising contacting a TMTHF precursor with a solid catalyst, wherein the TMTHF precursor is 2,5-dimethylhexane-2,5-dioland/or 2,5-dim...
|
|
WO/2018/033087A1 |
Disclosed are a compound using anthrone as a core and applications thereof. The compound uses anthrone as a parent core, which is connected to an aromatic heterocyclic group, so that the molecular symmetry is destroyed, the molecular cry...
|
|
WO/2018/031853A1 |
Disclosed is an optical compensation film made of a solution cast of a polymer blend comprising a nitrated styrenic fluoropolymer and a polyimide. The compensation film is a positive-C plate having reversed wavelength dispersion that is ...
|
|
WO/2018/029141A1 |
The invention relates to a method for producing 4-substituted 2,3-dihydro-1-benzofuran derivatives by cyclisation of 2-(2-diazonium-6-substituted phenyl)ethanol salts.
|
|
WO/2018/029202A1 |
The invention relates to an anionic surfactant of general formula (I) in which n and m are, independently of one another, numbers from 0 to 17 and 2 < n + m < 20, and X+ is a charge-balancing cation. The invention also relates to a produ...
|
|
WO/2018/028050A1 |
Disclosed is an asymmetric aryl-alkyl persulfate compound as represented by formula (3) and a synthesis method therefor, in which an arylboronic acid of formula (1) and R2SSCOR3 of formula (2) serve as reaction raw materials and, under t...
|
|
WO/2018/029710A1 |
The present invention relates to the furanochalcone class of compounds of general formula A. The present invention particularly relates to the synthesis of furanochalcones and their CYP1A1, CYP1A2 and CYP1B1 inhibitory activity. In addit...
|
|
WO/2018/031435A1 |
Herein are described chemotherapeutically active compositions that include a thermally activated saccharide. The thermally active saccharide (a chemotherapeutically active saccharide) can be selected from a thermally activated maltodextr...
|
|
WO/2018/024188A1 |
Provided are a polycyclic compound and a manufacturing method, pharmaceutical composition, and application thereof. The structure of the polycyclic compound and an isomer, prodrug, solvate, hydrate, stable isotopic derivative, or pharmac...
|
|
WO/2018/018863A1 |
Disclosed are a mild and efficient preparation method for an α-acyloxy alkenyl amide compound and a use thereof in the synthesis of an amide and a polypeptide. The α-acyloxy alkenyl amide compound is obtained by an addition reaction of...
|
|
WO/2018/022848A1 |
A2-73 is a useful therapeutic in the treatment of humans suffering from insomnia, anxiety or agitation. Particular attention is made to oral daily doses of from about 10mg to about 50mg, with particular reference to about 20 to 30mg.
|
|
WO/2018/019291A1 |
Provided is a method of synthesizing a C(sp3)-C(sp2) cross-coupled compound comprising reacting a C(sp3) coupling partner with a C(sp2) coupling partner, a catalyst, and a solvent; wherein the C(sp3) coupling partner comprises an organic...
|
|
WO/2018/018091A1 |
The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.
|
|
WO/2018/017382A1 |
Disclosed is an oxidation process to produce a crude carboxylic acid product carboxylic acid product. The process comprises oxidizing a feed stream comprising at least one oxidizable compound to generate a crude carboxylic acid slurry co...
|
|
WO/2018/016786A1 |
The present invention provides: a compound capable of implementing high luminous efficiency, a low driving voltage and improved lifespan of a device; an organic electronic device using the same; and an electronic apparatus thereof.
|
|
WO/2018/016898A1 |
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.
|
|
WO/2018/016742A1 |
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.
|
|
WO/2018/018035A1 |
Prodrugs and derivatives of 5-hydoxymethyl-2-furfural (5-HMF) with protected or modified aldehyde and/or alcohol moieties are provided. The prodrugs or derivatives exhibit increased bioavailability, e.g. due to having extended half-lives...
|
|
WO/2018/014834A1 |
Disclosed are a 3-hydrocarbyl-5,6-dioxy-substituted phthalide compound and a preparation method and use thereof. The structure of the phthalide compound is as shown in formula (I): wherein the definitions of R1, R2 and R3 are as describe...
|
|
WO/2018/016724A1 |
The present invention relates to a compound for an organic optoelectronic device represented by chemical formula 1, a composition for an organic optoelectronic device, an organic optoelectronic device using the same, and a display device...
|
|
WO/2018/012762A1 |
The present invention relates to a novel compound and an organic electroluminescent device comprising same. The compound, according to the present invention, can be used in an organic layer, preferably a light-emitting layer, of an organ...
|
|
WO/2018/012426A1 |
Provided is a method for efficiently producing mucic acid from a commonly used organic raw material such as glucose or galactose. Provided is a method for producing mucic acid in which glucose or galactose is used as a starting material ...
|
|
WO/2018/007764A1 |
The invention relates to a method for converting levoglucosenone into 4-hydroxymethyl butyrolactone and 4-hydroxymethyl butenolide without using any solvent or catalyst, wherein the oxidation and hydrolysis of the levoglucosenone or hydr...
|
|
WO/2018/008737A1 |
The present invention addresses the problem of providing a compound which exerts its effect on the onset mechanism of Parkinson's disease by inhibiting the degeneration and cell death of dopamine-secreting cells, and a therapeutic or pro...
|
|
WO/2018/008442A1 |
The purpose of the present invention is to provide: a π-conjugated compound exhibiting excellent light emission characteristics; an organic electroluminescent element using same; a display device; and an illumination device. Accordingly...
|
|
WO/2018/007198A1 |
The present invention relates to the preparation of Thapsigargin (1) and Nortrilobolide (2). The invention further relates to intermediates and preparation of said intermediates which are useful for the preparation of (1) and (2).
|
|
WO/2018/003968A1 |
The purpose of the present invention is to provide an industrial production method by which an ethylenically unsaturated group-containing γ-butyrolactone derivative is highly selectively obtained with use of a low-cost catalyst that is ...
|
|
WO/2018/002291A1 |
The invention relates to a process for preparing 2,5-furandicarboxylic acid (FDCA) from furfuryl alcohol comprising: i) preparing 2,5-bis(hydroxymethyl)furan (BHMF) by hydroxymethylation of furfuryl alcohol by formaldehyde in aqueous sol...
|
|
WO/2018/004095A1 |
The present invention relates to a compound, for an organic optoelectronic device, expressed by chemical formula (1), a composition for an organic optoelectronic device, an organic optoelectronic device having applied same, and a display...
|
|
WO/2018/004315A2 |
The present specification relates to a compound of chemical formula 1 and an organic electronic element comprising the same.
|
|
WO/2018/003945A1 |
[Problem] Provided are a method for producing 2-propanil 4-{(3S,5aR,6R,7R,8aS)-6-[(1E,3R)-4-(2,5-difluorophenoxy)-3-h
ydroxy-1-butene-1-yl]-7-hydroxyoctahydro-2H-cyclopenta[b]oxe
pine-3-yl}butanoate, which can solve various problems desc...
|
|
WO/2018/003295A1 |
The present invention addresses the problem of providing: a 5-hydroxymethyl-2-furfural (5-HMF) production method which is suitable for the production of 5-hydroxymethyl-2-furfural (5-HMF) on an industrial scale; and a novel catalyst comp...
|
|
WO/2018/004461A1 |
Disclosed herein is a catalyst composition that contains M0O3 supported on a carbonaceous material substrate, wherein MoO3 is present in an amount of from 2.0 wt% to 20.0 wt% of the composition and carbon is present in an amount of from ...
|
|
WO/2017/222532A1 |
A process for the preparation of diastereomeric mono- and 2,5- bis(halomethyl)tetrahydrofurans from renewable THF-diols is described. Also disclosed are certain derivative compounds that can be prepared from the mono or di-alkyl halide f...
|
|
WO/2017/220041A2 |
Disclosed are a bezafibrate pharmaceutical composition and an application thereof in rheumatoid arthritis. The bezafibrate pharmaceutical composition contains bezafibrate and a natural product compound (I) separated from dried clove buds...
|
|
WO/2017/223151A1 |
The present disclosure provides a composition containing a sulfonamide aliphatic anhydride grafted olefin-based polymer. The present disclosure also provides a multilayer structure. In an embodiment, a multilayer film is provided and inc...
|
|
WO/2017/223164A1 |
The present disclosure provides a process for producing an aliphatic sulfonyl azide anhydride and the resultant aliphatic sulfonyl azide anhydride composition. The process includes: (i) thio-acetoxylating an alkenyl carboxylic acid anhyd...
|
|
WO/2017/222953A1 |
Disclosed are compounds that modulate the physiological action of the proprotein convertase subtilisin kexin type 9 (PCSK9), as well as therapeutic methods for use of such compounds to reduce LDL-cholesterol levels and/or for the treatme...
|
|
WO/2017/220042A2 |
Disclosed are an amrinone pharmaceutical composition and an application thereof in hypertension treatment. The amrinone pharmaceutical composition contains amrinone and a natural product compound (I) separated from dried blackberry lily ...
|
|
WO/2017/215676A1 |
A carbidopa pharmaceutical composition and medical use thereof for treating liver cancer are provided. The carbidopa pharmaceutical composition provided in the present invention comprises carbidopa and a naturally produced compound (I) h...
|
|
WO/2017/217676A1 |
The present invention relates to a novel compound having excellent thermal stability and luminescent ability, and an organic electroluminescent element having enhanced characteristics such as luminous efficiency, driving voltage, and lif...
|
|
WO/2017/217792A1 |
The present invention relates to an improved method for producing a diphenylmethane derivative which is effective as a sodium-dependent glucose cotransporter (SGLT) inhibitor, the method being carried out by means of a convergent synthes...
|
|
WO/2017/215549A1 |
Disclosed are an organic electroluminescent compound and an application thereof. The structural formula of the compound is as shown in general formula (1). The material has good fluorescence quantum efficiency and electroluminescence eff...
|
|
WO/2017/217741A1 |
The present invention relates to a novel brominated furanone derivative, a method for preparing the same, and a pharmaceutical composition containing the same as an active ingredient, wherein the novel brominated furanone derivative or a...
|
|
WO/2017/214493A1 |
A synthetic fuel is provided. The synthetic fuel includes a base fuel having a first energy density and a compound, the compound including a water absorbing agent for absorbing water from the base fuel to prevent poor combustion and an e...
|
|
WO/2017/214334A1 |
Disclosed herein are lignin-derived ionic liquids and methods for preparing them. The methods include forming a reaction mixture comprising a lignin-derived starting material, a carbonyl compound, and an amine; maintaining the reaction m...
|
|
WO/2017/209294A1 |
According to the present invention, it is possible to safely and easily obtain sulfonimidized aromatic compounds using various substrates and a novel sulfonimidization agent by irradiating, with light in the presence of an oxidizer, a co...
|
|
WO/2017/208965A1 |
The present invention provides an organic compound characterized by being represented by general formula [1] set forth in the claims. In general formula [1], Ar1 and Ar2 are each independently selected from among aryl groups having 6-18 ...
|
